BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16443242)

  • 21. Motor effects of delta 9 THC in cerebellar Lurcher mutant mice.
    Lorivel T; Hilber P
    Behav Brain Res; 2007 Aug; 181(2):248-53. PubMed ID: 17531329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delta-9-tetrahydrocannabinol accumulation, metabolism and cell-type-specific adverse effects in aggregating brain cell cultures.
    Monnet-Tschudi F; Hazekamp A; Perret N; Zurich MG; Mangin P; Giroud C; Honegger P
    Toxicol Appl Pharmacol; 2008 Apr; 228(1):8-16. PubMed ID: 18083204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of cannabidiol and tetrahydrocannabinol on motion-induced emesis in Suncus murinus.
    Cluny NL; Naylor RJ; Whittle BA; Javid FA
    Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):150-6. PubMed ID: 18816298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anabolic-androgenic steroid treatment induces behavioral disinhibition and downregulation of serotonin receptor messenger RNA in the prefrontal cortex and amygdala of male mice.
    Ambar G; Chiavegatto S
    Genes Brain Behav; 2009 Mar; 8(2):161-73. PubMed ID: 19055689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The endocannabinoid system: emotion, learning and addiction.
    Moreira FA; Lutz B
    Addict Biol; 2008 Jun; 13(2):196-212. PubMed ID: 18422832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids.
    Börner C; Höllt V; Sebald W; Kraus J
    J Leukoc Biol; 2007 Jan; 81(1):336-43. PubMed ID: 17041005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system.
    Zarrindast MR; Sarahroodi S; Arzi A; Khodayar MJ; Taheri-Shalmani S; Rezayof A
    Behav Pharmacol; 2008 Oct; 19(7):716-23. PubMed ID: 18797248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocrine aspects of cannabinoid action in female subprimates: search for sites of action.
    Tyrey L
    NIDA Res Monogr; 1984; 44():65-81. PubMed ID: 6090910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal neurones and glia.
    Ryan D; Drysdale AJ; Pertwee RG; Platt B
    Neurosci Lett; 2006 Nov; 408(3):236-41. PubMed ID: 16997463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term consequences of a single treatment of mice with an ultra-low dose of Delta9-tetrahydrocannabinol (THC).
    Amal H; Fridman-Rozevich L; Senn R; Strelnikov A; Gafni M; Keren O; Sarne Y
    Behav Brain Res; 2010 Jan; 206(2):245-53. PubMed ID: 19766676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stacking anabolic androgenic steroids (AAS) during puberty in rats: a neuroendocrine and behavioral assessment.
    Wesson DW; McGinnis MY
    Pharmacol Biochem Behav; 2006 Mar; 83(3):410-9. PubMed ID: 16603236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of THC-induced effects on the central nervous system and heart rate by a novel CB1 receptor antagonist AVE1625.
    Zuurman L; Roy C; Schoemaker RC; Amatsaleh A; Guimaeres L; Pinquier JL; Cohen AF; van Gerven JM
    J Psychopharmacol; 2010 Mar; 24(3):363-71. PubMed ID: 18801827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fungal biotransformation of cannabinoids: potential for new effective drugs.
    Saxena S
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):305-12. PubMed ID: 19333876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reinforcing aspects of androgens.
    Wood RI
    Physiol Behav; 2004 Nov; 83(2):279-89. PubMed ID: 15488545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Administration of the anabolic androgenic steroid nandrolone decanoate affects substance P endopeptidase-like activity in the rat brain.
    Magnusson K; Hallberg M; Högberg AM; Nyberg F
    Peptides; 2006 Jan; 27(1):114-21. PubMed ID: 16099548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic Delta9-tetrahydrocannabinol treatment produces antinociceptive tolerance in mice without altering protein kinase A activity in mouse brain and spinal cord.
    Dalton GD; Smith FL; Smith PA; Dewey WL
    Biochem Pharmacol; 2005 Jul; 70(1):152-60. PubMed ID: 15913565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoid tolerance and dependence: a review of studies in laboratory animals.
    González S; Cebeira M; Fernández-Ruiz J
    Pharmacol Biochem Behav; 2005 Jun; 81(2):300-18. PubMed ID: 15919107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher physiological doses of nandrolone decanoate do not influence the Bezold-Jarish reflex control of bradycardia.
    Andrade TU; Santos MC; Busato VC; Medeiros AR; Abreu GR; Moysés MR; Bissoli NS
    Arch Med Res; 2008 Jan; 39(1):27-32. PubMed ID: 18067992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice.
    Balerio GN; Aso E; Maldonado R
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):504-13. PubMed ID: 16416159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part II: comparison of behavioural effects of pulmonary versus parenteral cannabinoid exposure in rodents.
    Manwell LA; Ford B; Matthews BA; Heipel H; Mallet PE
    J Pharmacol Toxicol Methods; 2014; 70(1):112-9. PubMed ID: 24956154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.